No significant difference in risk of heart failure hospitalization with vildagliptin in diabetic patients with systolic chronic heart failure: VIVIDD study (Poster no. 1028-P)

Henry Krum, Valentina Lukashevich, Geremia B. Bolli, Plamen Kozlovski, Wolfgang Kothny, Piotr Ponikowski

American Diabetes Association 2014

The presentation that you are looking for is no longer available on this site. Please contact Novartis Oncology Medical Information at 1-844-ONC-INFO (1-844-662-4636).



All copyrights protected by owners. Solely for non-commercial, personal use.